Literature DB >> 8542595

Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma.

N Yokota1, J Aruga, S Takai, K Yamada, M Hamazaki, T Iwase, H Sugimura, K Mikoshiba.   

Abstract

Zic is a novel zinc finger protein which displays a highly restricted expression pattern in the adult and developing mouse cerebellum and is highly homologous to the recently cloned Drosophila pair-rule gene Opa. To clarify the mechanism for the development of the human cerebellum and its involvement in human nervous system diseases, we have isolated human Zic cDNA and examined its expression by using monoclonal antibody against recombinant Zic protein. The nucleotide sequence of human Zic cDNA is 85% homologous to that of mouse Zic cDNA. Its putative amino acid sequence is highly conserved (> 99%) except for substitution of only two amino acid residues. In situ chromosome hybridization localized the human Zic gene to chromosome band 3q24. Human Zic protein was immunohistochemically detected in the nuclei of the cerebellar granule cell lineage from the progenitor cells of the external germinal layer to the postmigrated cells of the internal granular layer. Furthermore, Zic protein was detected in medulloblastoma (26/29 cases), whereas no other tumors examined (over 70 cases including primitive neuroectodermal tumors) expressed this protein. These findings suggest that Zic is a potential biomarker for medulloblastoma as well as the human cerebellar granule cell lineage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542595

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  An essential and highly conserved role for Zic3 in left-right patterning, gastrulation and convergent extension morphogenesis.

Authors:  Ashley E Cast; Chunlei Gao; Jeffrey D Amack; Stephanie M Ware
Journal:  Dev Biol       Date:  2012-01-21       Impact factor: 3.582

Review 2.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif.

Authors:  Amit Arora; Mariola Dutkiewicz; Vinod Scaria; Manoj Hariharan; Souvik Maiti; Jens Kurreck
Journal:  RNA       Date:  2008-05-30       Impact factor: 4.942

4.  Xenopus Zic3, a primary regulator both in neural and neural crest development.

Authors:  K Nakata; T Nagai; J Aruga; K Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Nestin Mediates Hedgehog Pathway Tumorigenesis.

Authors:  Peng Li; Eric H Lee; Fang Du; Renata E Gordon; Larra W Yuelling; Yongqiang Liu; Jessica M Y Ng; Hao Zhang; Jinhua Wu; Andrey Korshunov; Stefan M Pfister; Tom Curran; Zeng-Jie Yang
Journal:  Cancer Res       Date:  2016-08-05       Impact factor: 12.701

6.  Differential expression of SOX4 and SOX11 in medulloblastoma.

Authors:  Ching-Jung Lee; Vanessa J Appleby; Alex T Orme; Wai-In Chan; Paul J Scotting
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 7.  Medulloblastoma: molecular genetics and animal models.

Authors:  Corey Raffel
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

8.  Effects of basic fibroblastic growth factor on the growth of human medulloblastoma xenografts.

Authors:  Pascal Vachon; Christiane Girard; Yves Théorêt
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 9.  Medulloblastoma: from molecular pathology to therapy.

Authors:  Alessandra Rossi; Valentina Caracciolo; Giuseppe Russo; Krzysztof Reiss; Antonio Giordano
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

10.  Expression of ZIC family genes in meningiomas and other brain tumors.

Authors:  Jun Aruga; Yayoi Nozaki; Minoru Hatayama; Yuri S Odaka; Naoki Yokota
Journal:  BMC Cancer       Date:  2010-03-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.